文献速递主动脉外科

常温髂动脉灌注改善胸腹主动脉瘤修复早期结局

Normothermic iliac perfusion improves early outcomes after thoraco-abdominal aortic aneurysm repair.
PubMed 文献 · Eur J Cardiothorac Surg · 2019-01-01

本研究对比常温髂动脉灌注与深低温停循环在Crawford II型胸腹主动脉瘤修复中的安全性和有效性。倾向性评分匹配后,常温灌注组无早期手术死亡,复合并发症发生率更低,但中期生存率无显著差异。

要点

  • 常温髂动脉灌注可降低Crawford II型胸腹主动脉瘤修复的早期手术死亡。
  • 常温灌注组复合并发症发生率显著低于深低温停循环组。
  • 年龄>50岁、深低温和慢性肾功能不全是早期手术死亡的独立危险因素。

核心结论

  • 常温髂动脉灌注是胸腹主动脉瘤修复的可行替代方案,可减少早期手术死亡和复合并发症。

主要发现

  • 匹配后A组早期手术死亡0例(0.0%),B组4例(6.9%),差异有统计学意义(P=0.047)。
  • 复合并发症A组11例(21.0%),B组21例(36.2%),差异有统计学意义(P=0.038)。
  • 年龄>50岁(OR 6.50,95%CI 2.32-16.36;P=0.020)、深低温(OR 12.13,95%CI 1.64-23.13;P=0.003)和慢性肾功能不全(OR 8.21,95%CI 2.34-43.33;P<0.001)是早期手术死亡的独立危险因素。
  • 3年、5年、7年生存率A组分别为98.3%、98.3%、86.9%,B组均为86.9%(P=0.471);7年再干预累积发生率A组0.026%,B组0.048%(P=0.625)。

关键数值与推荐

  • 倾向性评分匹配后,A组早期手术死亡0.0%(0/58),B组6.9%(4/58),P=0.047。
  • 复合并发症A组21.0%(11/58),B组36.2%(21/58),P=0.038。
  • 早期手术死亡独立危险因素:年龄>50岁OR 6.50(95%CI 2.32-16.36;P=0.020),深低温OR 12.13(95%CI 1.64-23.13;P=0.003),慢性肾功能不全OR 8.21(95%CI 2.34-43.33;P<0.001)。

临床怎么用

  • 对于Crawford II型胸腹主动脉瘤修复,常温髂动脉灌注可考虑作为深低温停循环的替代策略以改善早期结局。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The aim of this study is to evaluate the safety and efficacy of thoraco-abdominal aortic aneurysm repair with normothermic iliac perfusion. METHODS: One hundred and ninety patients who underwent aortic replacement for the Crawford type II thoraco-abdominal aortic aneurysm between January 2005 and June 2017 were assigned to 2 groups: normothermic iliac perfusion (group A, n = 75) and deep hypothermic circulatory arrest (group B, n = 115). We selected 58 pairs of patients for propensity score matching. We analysed early operative death, a composite of complications and mid-term survival. RESULTS: After propensity score matching, no early operative death occurred in group A (0.0%), and group B had 4 cases of early operative death (6.9%), with a statistically significant difference (P = 0.047). The composite of complications was reported in 11 patients in group A (21.0%) and in 21 patients in group B (36.2%) (P = 0.038). Age >50 years [odds ratio (OR) 6.50, 95% confidence interval (CI) 2.32-16.36; P = 0.020], deep hypothermia (OR 12.13, 95% CI 1.64-23.13; P = 0.003) and chronic renal insufficiency (OR 8.21, 95% CI 2.34-43.33; P < 0.001) were independent risk factors for early operative death. The 3-year, 5-year and 7-year survival rates were 98.3%, 98.3% and 86.9% in group A and 86.9%, 86.9% and 86.9% in group B, respectively (P = 0.471). The 7-year cumulative incidence function rates for reintervention were 0.026% in group A and 0.048% in group B (P = 0.625). CONCLUSIONS: Normothermic iliac perfusion provides a viable alternative for thoraco-abdominal aortic aneurysm repair, which reduced early operative death and composited complications.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Zhang L, Yu C, Yang X, et al. Normothermic iliac perfusion improves early outcomes after thoraco-abdominal aortic aneurysm repair. Eur J Cardiothorac Surg. 2019. PMID: 30590503. doi:10.1093/ejcts/ezy440

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。